PURPOSE: Epilepsy is a major clinical and social issue in Africa. This study was conducted to estimate the prevalence, incidence, mortality, and therapeutic outcome in rural Djidja in Benin. METHODS: This was a two-phase study with a cross-sectional phase and 18 months of follow-up. In the first phase, information was obtained using door-to-door surveys, reports from key informants, and medical sources. People were interviewed using a validated screening questionnaire for epilepsy in tropical regions. The diagnosis of epilepsy was confirmed by a neurologist. We used a capture-recapture method to estimate the number of people with epilepsy (PWE). PWE were followed every month for 18 months after the cross-sectional survey. We asked the health services, the general population, and village leaders in the study area to identify suspected cases of epilepsy occurring during the follow-up. New cases were updated every month after confirmation. Antiepileptic drugs were prescribed to PWE. KEY FINDINGS: We surveyed 11,668 subjects (male-to-female ratio 0.9) and identified 123 PWE, yielding a prevalence of 10.5 per 1,000 (95% confidence interval (CI) 8.8-12.6/1,000). Combining the three sources, we found 148 PWE and a prevalence of 12.7 per 1,000 (95% CI 10.7-14.9/1,000). After application of the capture-recapture method, the prevalence was estimated to be as high as 38.4 per 1,000 (95% CI 34.9-41.9/1,000). The cumulative incidence was 104.2 per 100,000 and the mean annual incidence was 69.4 per 100,000. The mean annual mortality was 20.8 per 1,000. After treatment, 45% of PWE had total seizure remission and 35% had a decrease in the number of seizures. SIGNIFICANCE: This study shows that door-to-door survey findings could be improved by using information from other sources. The follow-up suggests that epilepsy could be controlled. Continuous drug delivery and regular follow-up are key. Wiley Periodicals, Inc.
PURPOSE:Epilepsy is a major clinical and social issue in Africa. This study was conducted to estimate the prevalence, incidence, mortality, and therapeutic outcome in rural Djidja in Benin. METHODS: This was a two-phase study with a cross-sectional phase and 18 months of follow-up. In the first phase, information was obtained using door-to-door surveys, reports from key informants, and medical sources. People were interviewed using a validated screening questionnaire for epilepsy in tropical regions. The diagnosis of epilepsy was confirmed by a neurologist. We used a capture-recapture method to estimate the number of people with epilepsy (PWE). PWE were followed every month for 18 months after the cross-sectional survey. We asked the health services, the general population, and village leaders in the study area to identify suspected cases of epilepsy occurring during the follow-up. New cases were updated every month after confirmation. Antiepileptic drugs were prescribed to PWE. KEY FINDINGS: We surveyed 11,668 subjects (male-to-female ratio 0.9) and identified 123 PWE, yielding a prevalence of 10.5 per 1,000 (95% confidence interval (CI) 8.8-12.6/1,000). Combining the three sources, we found 148 PWE and a prevalence of 12.7 per 1,000 (95% CI 10.7-14.9/1,000). After application of the capture-recapture method, the prevalence was estimated to be as high as 38.4 per 1,000 (95% CI 34.9-41.9/1,000). The cumulative incidence was 104.2 per 100,000 and the mean annual incidence was 69.4 per 100,000. The mean annual mortality was 20.8 per 1,000. After treatment, 45% of PWE had total seizure remission and 35% had a decrease in the number of seizures. SIGNIFICANCE: This study shows that door-to-door survey findings could be improved by using information from other sources. The follow-up suggests that epilepsy could be controlled. Continuous drug delivery and regular follow-up are key. Wiley Periodicals, Inc.
Authors: Kenneth Ayuurebobi Ae-Ngibise; Bright Akpalu; Anthony Ngugi; Albert Akpalu; Francis Agbokey; Patrick Adjei; Damien Punguyire; Christian Bottomley; Charles Newton; Seth Owusu-Agyei Journal: Pan Afr Med J Date: 2015-05-13
Authors: Ryan G Wagner; Christian Bottomley; Anthony K Ngugi; Fredrick Ibinda; F Xavier Gómez-Olivé; Kathleen Kahn; Stephen Tollman; Charles R Newton; Ryan Wagner; Rhian Twine; Myles Connor; Mark Collinson; Honratio Masanja; Alexander Mathew; Angelina Kakooza; George Pariyo; Stefan Peterson; Donald Ndyo-mughenyi; Rachael Odhiambo; Eddie Chengo; Martin Chabi; Evasius Bauni; Gathoni Kamuyu; Victor Mung'ala Odera; James O Mageto; Ken Ae-Ngibise; Bright Akpalu; Albert Akpalu; Francis Agbokey; Patrick Adjei; Seth Owusu-Agyei; Immo Kleinschmidt; Victor C K Doku; Peter Odermatt; Brian Neville; Josemir W Sander; Steve White; Thomas Nutman; Patricia Wilkins; John Noh Journal: PLoS One Date: 2015-06-08 Impact factor: 3.240
Authors: Anthony K Ngugi; Christian Bottomley; J Anthony G Scott; Victor Mung'ala-Odera; Evasius Bauni; Josemir W Sander; Immo Kleinschmidt; Charles R Newton Journal: Epilepsia Date: 2013-06-10 Impact factor: 6.740
Authors: Oscar H Del Brutto; Pablo R Castillo; Mark J Sedler; Victor J Del Brutto; Mauricio Zambrano; Robertino M Mera; Clinton B Wright; Tatjana Rundek Journal: J Environ Public Health Date: 2018-11-26